Gavrilov Ognian Anguelov - 09 Mar 2026 SCHEDULE 13D Report for Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value (CLDI)

Filing Manager: Gavrilov Ognian Anguelov
Reporting Manager: Gavrilov Ognian Anguelov
Security: Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value
Symbol: CLDI
Shares outstanding: 7,142,857 shares
Disclosed Ownership: 700,000 shares
Ownership: 9.8%
Form type: SCHEDULE 13D
Filing time: 09 Mar 2026, 13:15:12 UTC
Date of event: 09 Mar 2026
Previous filing: 04 Feb 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Gavrilov Ognian Anguelov	9.8%	700,000	700,000	0	Ognian Anguelov Gavrilov	Managing Partner	0002109116